Arthritis, Juvenile: all 359 studies
Page 1 of 4. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.
- Development of a Multidimensional Prediction Model for the Course and Outcome of Early-Onset Juvenile Idiopathic Arthritis (JIA)RecruitingNCT07882667
- Pulmonary Involvement in Children With Systemic JIANot yet recruitingNCT07882381
- Allogeneic Hematopoietic Cell Transplantation for Refractory Systemic Juvenile Idiopathic Arthritis.RecruitingNCT07845942
- Clinical Features and Treatment of Systemic JIA in ChildrenNot yet recruitingNCT07814963
- Oral Health, Saliva Bacteria, and Disease Activity in Children With JIA: A Cross-Sectional Study.RecruitingNCT07799831
- Pain-Sleep in Rheumatic DiseaseNot yet recruitingNCT07775612Not applicable
- A Study to Evaluate Pharmacokinetics of DRL_AB in Healthy Male ParticipantsNot yet recruitingNCT07744828Phase 1
- Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular ResearchNot yet recruitingNCT07737470
- Sarcopenia and Juvenile Idiopathic ArthritisNot yet recruitingNCT07634354Not applicable
- Study of the Efficacy and Safety of Goflikicept and Olokizumab as the Second-line Therapy in Patients With Still's DiseaseNot yet recruitingNCT07625384Phase 3
- Validity and Reliability of the International Physical Fitness Questionnaire and the Self-Perceived Health-Related Physical Fitness Questionnaire in Children and Adolescents With JIA and FMFNot yet recruitingNCT07617558
- Biopsychosocial Risk Influences on the Development and Generation of Early-Onset Chronic PainRecruitingNCT07602595
- Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Idiopathic Arthritis in Children and AdolescentsRecruitingNCT07554495Phase 3
- Tenosynovitis in Polyarticular and Oligoarticular Juvenile Idiopathic ArthritisNot yet recruitingNCT07553910
- OLE Study With Filgotinib in JIARecruitingNCT07553182Phase 3
- Pharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic ArthritisRecruitingNCT07517575Phase 2
- A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease PatientsRecruitingNCT07517250
- Scoliosis and Functional Outcomes in Children With Juvenile Idiopathic ArthritisNot yet recruitingNCT07433894
- Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic ArthritisEnrolling by invitationNCT07386587Phase 3
- Hypnotherapy for Needle-related Procedural Pain and Anxiety Management in a Pediatric SettingNot yet recruitingNCT07349667Not applicable
- Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in KoreaRecruitingNCT07243782
- Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic ArthritisRecruitingNCT07234747Not applicable
- Pain in Juvenile ArthritisRecruitingNCT07217782Not applicable
- Tofacitinib in Juvenile Idiopathic ArthritisNot yet recruitingNCT07211932
- A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's DiseaseRecruitingNCT07203001Phase 2
- Long Term Treatment Strategies and Effectiveness of Secukinumab in Patient With JIA Subtypes of JPsA and ERA: Study From German BIKER Registry.Not yet recruitingNCT07190053
- Investigation of Catastrophizing of Pain Reported by Parents in JIA PatientsRecruitingNCT07185750
- Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic DiseasesRecruitingNCT07184450Phase 1
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingNCT07138898Phase 2
- Clinical Autoinflammatory Disease CohortNot yet recruitingNCT07126145
- Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic DiseasesRecruitingNCT07087912Phase 4
- Assessment of Composite Inflammatory Ratios in Juvenile Idiopathic Arthritis and Their Association With Disease ActivityNot yet recruitingNCT07083466
- EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular DiseasesRecruitingNCT07077304
- Quantification & Classification of Inflammatory Cells in Uveitis Using OCTRecruitingNCT07065747
- Medical Follow-up of New Cases of Polyarthritis in Children and Young AdultsRecruitingNCT07000916
- Articular Damage in Patients With Juvenile Idiopathic Arthritis After Transition to Adult CareNot yet recruitingNCT06895278
- Mesenchymal Stem Cells Infusion in Patients With Autoimmune DiseasesEnrolling by invitationNCT06888973Phase 1/2
- Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic ArthritisRecruitingNCT06874608Not applicable
- Dynamic Gait Index as a Functional Gait Assessment Measure in Children With JIARecruitingNCT06870045
- A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic ArthritisRecruitingNCT06869551Phase 3
- Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study.RecruitingNCT06862843
- Ilaris NIS in KoreaRecruitingNCT06838143
- Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopathic ArthritisRecruitingNCT06806774
- Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic DiseasesEnrolling by invitationNCT06763783Phase 4
- Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).RecruitingNCT06751238Phase 1
- Pain in Inflammatory Joint DiseasesRecruitingNCT06718569
- Role of Interleukin 18 (IL-18) and Interleukin 18 Binding Protein (IL-18BP) in the Diagnostic Work-up of Systemic Juvenile Idiopathic Arthritis and Autoinflammatory Diseases: Possible Biomarkers in the Differential Diagnosis of Other Febrile DiseasesNot yet recruitingNCT06718049
- Gait Profile and Variables in Pediatric Rheumatic Disease Using a Smart Insole SystemNot yet recruitingNCT06705673
- An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic ArthritisRecruitingNCT06668181Phase 3
- A Long-term Extension (LTE) Study of Guselkumab in Pediatric ParticipantsRecruitingNCT06663332Phase 3
- Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic ArthritisRecruitingNCT06654882Phase 3
- Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA TrialRecruitingNCT06653634Phase 4
- Toward Personalized Medicine to Guide Drug Withdrawal in Children with Juvenile Idiopathic Arthritis in Clinical RemissionNot yet recruitingNCT06618937Phase 4
- UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic DiseaseRecruitingNCT06560606
- Feasibility of a Diet Intervention for Juvenile ArthritisRecruitingNCT06474546Not applicable
- The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic ArthritisRecruitingNCT06463379Phase 3
- Analysis of Peripheral Blood Lymphocytes in Patients With Juvenile Idiopathic Arthritis With Respect to Disease Subtypes and TherapyNot yet recruitingNCT06413563
- The Reliability and Validity of the Ankylosing Spondylitis Performance Index (ASPI) in Enthesitis-Related ArthritisRecruitingNCT06383195
- M3-JIA: Making Mindfulness Matter for Children With JIARecruitingNCT06376149Not applicable
- Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE StudyRecruitingNCT06339177
- Virtual Self-Management Program for JIARecruitingNCT06184100Not applicable
- Immersive Virtual Reality Exergaming Program in Adolescents Diagnosed With Juvenile Idiopathic ArthritisRecruitingNCT06176846Not applicable
- A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or AdalimumabRecruitingNCT06100744Phase 3
- Fibrinogen to Albumin Ratio and C-reactive Protein to Albumin Ratio in Juvenile Idiopathic ArthritisNot yet recruitingNCT06024486
- Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention.Not yet recruitingNCT06007885Not applicable
- Clinical, Laboratory and Ultrasound Stratification of Patients With Juvenile Idiopathic ArthritisRecruitingNCT06007456
- Imaging Based Uveitis Screening for Children With Juvenile Idiopathic ArthritisNot yet recruitingNCT05984758Not applicable
- Acostill ( RaDiCo Cohort) (RaDiCo Acostill)RecruitingNCT05927454
- Coenzyme Q10 in Juvenile Idiopathic Arthritis PatientsRecruitingNCT05871086Phase 2/3
- Downstream Effects of Personalized 'Top-down' Participation-based Interventions Among Youth With Physical DisabilitiesNot yet recruitingNCT05784285Not applicable
- A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic ArthritisRecruitingNCT05767047Phase 3
- Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic ArthritisRecruitingNCT05754710
- Serum Interleukin - 17A in Juvenile Idiopathic ArthritisNot yet recruitingNCT05688358
- Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.RecruitingNCT05609630Phase 3
- Interest of an Adapted Physical Activity (APA) Program Among Patients With Juvenile Idiopathic Arthritis: a Feasibility and Efficacy Preliminary StudyRecruitingNCT05572424Not applicable
- SARS Cov 2 Vaccination in Adolescents With Juvenile Idiopathic ArthritisRecruitingNCT05547451
- Angiogenic Biomarkers in Juvenile Idiopathic ArthritisRecruitingNCT05534347
- Personalized Estimates of Response and Severity Outcomes in Newly-diagnosed JIARecruitingNCT05310799Not applicable
- AutoInflammatory Disease Alliance Registry (AIDA)RecruitingNCT05200715
- Auvergne-Rhône-Alpes-Limousin Research Database for Still's Diseases in Children and AdultsRecruitingNCT05055882
- Development of a Therapeutic Endpoint in Pediatric Rheumatologic ConditionsRecruitingNCT04833465
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruitingNCT04806620
- Apremilast Pediatric Study in Children With Active Juvenile Psoriatic ArthritisRecruitingNCT04804553Phase 3
- Health and Exercise Response in Children With Chronic and Auto-immune PathologiesRecruitingNCT03913962Not applicable
- A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic ArthritisRecruitingNCT03773965Phase 3
- STep-up and Step-down Therapeutic Strategies in Childhood ARthritiSRecruitingNCT03728478Phase 3
- CAPRI National Juvenile Idiopathic Arthritis RegistryRecruitingNCT03245801
- A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)RecruitingNCT02991469Phase 2
- Juvenile Arthritis Quantitative ImagingRecruitingNCT02684695
- Comparative Autoantibody and Immunologic Cell Marker StudyEnrolling by invitationNCT02422875
- Observational Study of Pediatric Rheumatic Diseases: The CARRA RegistryRecruitingNCT02418442
- Juvenile Inflammatory Rheumatism (JIR) CohorteEnrolling by invitationNCT02377245
- Glycosylated Ferritin in Macrophagic Activation SyndromesRecruitingNCT02143986
- Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCTRecruitingNCT01962415Phase 2
- Natural History and Development of SpondyloarthritisRecruitingNCT01422694
- Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) in JIATerminatedNCT05710640Phase 2Results posted
- Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLECompletedNCT05001737Phase 3Results posted
- COVID-19 Booster Vaccine in Autoimmune Disease Non-RespondersTerminatedNCT05000216Phase 2Results posted
- A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic ArthritisActive, not recruitingNCT04527380Phase 3Results posted
- Sleep Innovations for Preschoolers With Arthritis (SIPA): Developing and Pilot Testing of a Self-Management InterventionCompletedNCT04354337Not applicableResults posted